Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer's Association International Conferences [Yahoo! Finance]
Alpha Cognition Inc. (ACOG)
Company Research
Source: Yahoo! Finance
the "Company"), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced it will present new clinical data on ZUNVEYL at the American Association of Geriatric Psychiatrists (AAGP), taking place April 16-20, 2026 and the Neuroscience Education Institute (NEI) Spring Congress, taking place May 1-3, 2026. The Company will share the following poster presentations: Beyond Cholinesterase Inhibition: The Clinical Benefits of Galantamine- and Benzgalantamine-Mediated Nicotinic Receptor Modulation in Alzheimer's Disease Presenter: Kurt Grady, PharmD (Poster S49) Presentation: April 18, 5:30pm EST Literature Review: Acetylcholinesterase Inhibitors and Delayed Nursing Home Placement in Alzheimer's Disease Presenter: Pavel Svintozelskiy, PharmD (Poster S45) Presentation: April 18, 5:30pm EST Acetylcholinesterase Inhibitors and Psychotropic Medication Use in Alzheimer's Disease and Related Dementias (ADRD) Presenter: P
Show less
Read more
Impact Snapshot
Event Time:
ACOG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACOG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACOG alerts
High impacting Alpha Cognition Inc. news events
Weekly update
A roundup of the hottest topics
ACOG
News
- Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026Business Wire
- Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International ConferencesBusiness Wire
- Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study [Yahoo! Finance]Yahoo! Finance
- Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness StudyBusiness Wire
- Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing RegimensBusiness Wire
ACOG
Analyst Actions
- 12/19/25 - HC Wainwright
ACOG
Sec Filings
- 3/13/26 - Form 4
- 3/10/26 - Form 4
- 3/6/26 - Form 4
- ACOG's page on the SEC website